Edgewise Therapeutics (EWTX) Stock Forecast & Price Target

$34.48

+0.48 (+1.41%)

(As of 11/4/2024 ET)

Edgewise Therapeutics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 5 Analyst Ratings

Sell
0

Hold
0

Buy
5

Based on 5 Wall Street analysts who have issued ratings for Edgewise Therapeutics in the last 12 months, the stock has a consensus rating of "Buy." Out of the 5 analysts, 5 have given a buy rating for EWTX.

Consensus Price Target

$35.60
3.25% Upside

According to the 5 analysts' twelve-month price targets for Edgewise Therapeutics, the average price target is $35.60. The highest price target for EWTX is $51.00, while the lowest price target for EWTX is $31.00. The average price target represents a forecasted upside of 3.25% from the current price of $34.48.

Get the Latest News and Ratings for EWTX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Edgewise Therapeutics and its competitors.

EWTX Analyst Ratings Over Time

Type	Current Forecast 11/6/23 to 11/5/24	1 Month Ago 10/7/23 to 10/6/24	3 Months Ago 8/8/23 to 8/7/24	1 Year Ago 11/6/22 to 11/6/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)	3 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$35.60	$35.00	$33.20	$26.00
Forecasted Upside	3.25% Upside	23.24% Upside	109.07% Upside	295.14% Upside
Consensus Rating	Buy	Buy	Buy	Buy

A new way to play the AI boom (act before November 19) (Ad)

There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as little as $16 and a brokerage account.

Click here to get the ticker >>>

EWTX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EWTX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Edgewise Therapeutics Stock vs. The Competition

Type	Edgewise Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.79	2.50
Consensus Rating	Buy	Moderate Buy	Hold
Predicted Upside	3.25% Upside	16,383.96% Upside	10.47% Upside
News Sentiment Rating	Very Positive News See Recent EWTX News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
10/11/2024	Piper Sandler 2 of 5 stars	Boost Target	Overweight ➝ Overweight	$48.00 ➝ $51.00	+70.06%
9/19/2024	Truist Financial 2 of 5 stars	Boost Target	Buy ➝ Buy	$25.00 ➝ $33.00	+17.23%
9/17/2024	Royal Bank of Canada 4 of 5 stars	Reiterated Rating	Outperform ➝ Outperform	$32.00 ➝ $32.00	+72.88%
8/16/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$31.00 ➝ $31.00	+67.21%
8/12/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$30.00 ➝ $31.00	+89.83%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 06:27 AM ET.

EWTX Forecast - Frequently Asked Questions

: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Edgewise Therapeutics is $35.60, with a high forecast of $51.00 and a low forecast of $31.00.
: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Edgewise Therapeutics in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" EWTX shares.
: According to analysts, Edgewise Therapeutics's stock has a predicted upside of 3.25% based on their 12-month stock forecasts.
: Edgewise Therapeutics has been rated by research analysts at JPMorgan Chase & Co., Piper Sandler, Royal Bank of Canada, Truist Financial, and Wedbush in the past 90 days.
: Analysts like Edgewise Therapeutics more than other "medical" companies. The consensus rating for Edgewise Therapeutics is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how EWTX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This Bull Market Indicator called NVDA at $116 (Ad)

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

This page (NASDAQ:EWTX) was last updated on 11/5/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Edgewise Therapeutics (EWTX) Stock Forecast & Price Target